nodes	percent_of_prediction	percent_of_DWPC	metapath
Neomycin—Eye infection—Estradiol—prostate cancer	0.0393	0.0393	CcSEcCtD
Neomycin—Ototoxicity—Docetaxel—prostate cancer	0.0391	0.0391	CcSEcCtD
Neomycin—Nerve injury—Prednisone—prostate cancer	0.031	0.031	CcSEcCtD
Neomycin—Ulcerative keratitis—Prednisone—prostate cancer	0.0268	0.0268	CcSEcCtD
Neomycin—Cataract subcapsular—Prednisone—prostate cancer	0.026	0.026	CcSEcCtD
Neomycin—Swelling—Degarelix—prostate cancer	0.0225	0.0225	CcSEcCtD
Neomycin—Nephropathy toxic—Mitoxantrone—prostate cancer	0.0198	0.0198	CcSEcCtD
Neomycin—Secondary infection—Epirubicin—prostate cancer	0.018	0.018	CcSEcCtD
Neomycin—Secondary infection—Doxorubicin—prostate cancer	0.0167	0.0167	CcSEcCtD
Neomycin—Nephropathy toxic—Etoposide—prostate cancer	0.0165	0.0165	CcSEcCtD
Neomycin—Impaired healing—Prednisone—prostate cancer	0.0157	0.0157	CcSEcCtD
Neomycin—Sensitisation—Epirubicin—prostate cancer	0.0148	0.0148	CcSEcCtD
Neomycin—Sensitisation—Doxorubicin—prostate cancer	0.0137	0.0137	CcSEcCtD
Neomycin—Viral infection—Estradiol—prostate cancer	0.0135	0.0135	CcSEcCtD
Neomycin—Erythema—Flutamide—prostate cancer	0.0133	0.0133	CcSEcCtD
Neomycin—Swelling—Goserelin—prostate cancer	0.0127	0.0127	CcSEcCtD
Neomycin—Viral infection—Mitoxantrone—prostate cancer	0.0126	0.0126	CcSEcCtD
Neomycin—Swelling—Conjugated Estrogens—prostate cancer	0.0125	0.0125	CcSEcCtD
Neomycin—Erythema—Degarelix—prostate cancer	0.012	0.012	CcSEcCtD
Neomycin—Infection—Abiraterone—prostate cancer	0.0119	0.0119	CcSEcCtD
Neomycin—Anaphylactic shock—Estrone—prostate cancer	0.0118	0.0118	CcSEcCtD
Neomycin—Erythema—Cabazitaxel—prostate cancer	0.0113	0.0113	CcSEcCtD
Neomycin—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.0103	0.0103	CcSEcCtD
Neomycin—Swelling—Estradiol—prostate cancer	0.01	0.01	CcSEcCtD
Neomycin—Anaphylactic shock—Degarelix—prostate cancer	0.00976	0.00976	CcSEcCtD
Neomycin—Swelling—Mitoxantrone—prostate cancer	0.00935	0.00935	CcSEcCtD
Neomycin—Infection—Cabazitaxel—prostate cancer	0.00914	0.00914	CcSEcCtD
Neomycin—Glaucoma—Prednisone—prostate cancer	0.009	0.009	CcSEcCtD
Neomycin—Pruritus—Estramustine—prostate cancer	0.00871	0.00871	CcSEcCtD
Neomycin—Diarrhoea—Estramustine—prostate cancer	0.00843	0.00843	CcSEcCtD
Neomycin—Pruritus—Estrone—prostate cancer	0.00832	0.00832	CcSEcCtD
Neomycin—Diarrhoea—Abiraterone—prostate cancer	0.00818	0.00818	CcSEcCtD
Neomycin—Infection—Bicalutamide—prostate cancer	0.00784	0.00784	CcSEcCtD
Neomycin—Vomiting—Estramustine—prostate cancer	0.00783	0.00783	CcSEcCtD
Neomycin—Swelling—Etoposide—prostate cancer	0.00778	0.00778	CcSEcCtD
Neomycin—Pruritus—Nilutamide—prostate cancer	0.00773	0.00773	CcSEcCtD
Neomycin—Pruritus—Flutamide—prostate cancer	0.0077	0.0077	CcSEcCtD
Neomycin—Vomiting—Abiraterone—prostate cancer	0.00761	0.00761	CcSEcCtD
Neomycin—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.00757	0.00757	CcSEcCtD
Neomycin—Viral infection—Prednisone—prostate cancer	0.0075	0.0075	CcSEcCtD
Neomycin—Vomiting—Estrone—prostate cancer	0.00748	0.00748	CcSEcCtD
Neomycin—Diarrhoea—Nilutamide—prostate cancer	0.00748	0.00748	CcSEcCtD
Neomycin—Diarrhoea—Flutamide—prostate cancer	0.00744	0.00744	CcSEcCtD
Neomycin—Nausea—Estramustine—prostate cancer	0.00732	0.00732	CcSEcCtD
Neomycin—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00727	0.00727	CcSEcCtD
Neomycin—Hypersensitivity—Degarelix—prostate cancer	0.00719	0.00719	CcSEcCtD
Neomycin—Nausea—Estrone—prostate cancer	0.00699	0.00699	CcSEcCtD
Neomycin—Vomiting—Nilutamide—prostate cancer	0.00695	0.00695	CcSEcCtD
Neomycin—Vomiting—Flutamide—prostate cancer	0.00692	0.00692	CcSEcCtD
Neomycin—Pruritus—Degarelix—prostate cancer	0.00691	0.00691	CcSEcCtD
Neomycin—Hypersensitivity—Cabazitaxel—prostate cancer	0.00678	0.00678	CcSEcCtD
Neomycin—Erythema—Goserelin—prostate cancer	0.00672	0.00672	CcSEcCtD
Neomycin—Diarrhoea—Degarelix—prostate cancer	0.00668	0.00668	CcSEcCtD
Neomycin—Erythema—Conjugated Estrogens—prostate cancer	0.00666	0.00666	CcSEcCtD
Neomycin—Infection—Ethinyl Estradiol—prostate cancer	0.00663	0.00663	CcSEcCtD
Neomycin—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00653	0.00653	CcSEcCtD
Neomycin—Nausea—Nilutamide—prostate cancer	0.00649	0.00649	CcSEcCtD
Neomycin—Swelling—Docetaxel—prostate cancer	0.00646	0.00646	CcSEcCtD
Neomycin—Nausea—Flutamide—prostate cancer	0.00646	0.00646	CcSEcCtD
Neomycin—Diarrhoea—Cabazitaxel—prostate cancer	0.00629	0.00629	CcSEcCtD
Neomycin—Swelling—Capecitabine—prostate cancer	0.00626	0.00626	CcSEcCtD
Neomycin—Vomiting—Degarelix—prostate cancer	0.00621	0.00621	CcSEcCtD
Neomycin—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.0061	0.0061	CcSEcCtD
Neomycin—Viral infection—Epirubicin—prostate cancer	0.00587	0.00587	CcSEcCtD
Neomycin—Vomiting—Cabazitaxel—prostate cancer	0.00585	0.00585	CcSEcCtD
Neomycin—Hypersensitivity—Bicalutamide—prostate cancer	0.00581	0.00581	CcSEcCtD
Neomycin—Nausea—Degarelix—prostate cancer	0.0058	0.0058	CcSEcCtD
Neomycin—Pruritus—Bicalutamide—prostate cancer	0.00558	0.00558	CcSEcCtD
Neomycin—Anaphylactic shock—Goserelin—prostate cancer	0.00549	0.00549	CcSEcCtD
Neomycin—Nausea—Cabazitaxel—prostate cancer	0.00546	0.00546	CcSEcCtD
Neomycin—Infection—Goserelin—prostate cancer	0.00545	0.00545	CcSEcCtD
Neomycin—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00544	0.00544	CcSEcCtD
Neomycin—Viral infection—Doxorubicin—prostate cancer	0.00543	0.00543	CcSEcCtD
Neomycin—Infection—Conjugated Estrogens—prostate cancer	0.0054	0.0054	CcSEcCtD
Neomycin—Diarrhoea—Bicalutamide—prostate cancer	0.0054	0.0054	CcSEcCtD
Neomycin—Erythema—Estradiol—prostate cancer	0.00533	0.00533	CcSEcCtD
Neomycin—Vomiting—Bicalutamide—prostate cancer	0.00502	0.00502	CcSEcCtD
Neomycin—Erythema—Mitoxantrone—prostate cancer	0.00497	0.00497	CcSEcCtD
Neomycin—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00491	0.00491	CcSEcCtD
Neomycin—Pruritus—Ethinyl Estradiol—prostate cancer	0.00472	0.00472	CcSEcCtD
Neomycin—Nausea—Bicalutamide—prostate cancer	0.00469	0.00469	CcSEcCtD
Neomycin—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00456	0.00456	CcSEcCtD
Neomycin—Anaphylactic shock—Estradiol—prostate cancer	0.00435	0.00435	CcSEcCtD
Neomycin—Infection—Estradiol—prostate cancer	0.00432	0.00432	CcSEcCtD
Neomycin—Vomiting—Ethinyl Estradiol—prostate cancer	0.00424	0.00424	CcSEcCtD
Neomycin—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00405	0.00405	CcSEcCtD
Neomycin—Hypersensitivity—Goserelin—prostate cancer	0.00404	0.00404	CcSEcCtD
Neomycin—Infection—Mitoxantrone—prostate cancer	0.00403	0.00403	CcSEcCtD
Neomycin—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00401	0.00401	CcSEcCtD
Neomycin—Nausea—Ethinyl Estradiol—prostate cancer	0.00396	0.00396	CcSEcCtD
Neomycin—Pruritus—Goserelin—prostate cancer	0.00388	0.00388	CcSEcCtD
Neomycin—Pruritus—Conjugated Estrogens—prostate cancer	0.00385	0.00385	CcSEcCtD
Neomycin—Diarrhoea—Goserelin—prostate cancer	0.00376	0.00376	CcSEcCtD
Neomycin—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00372	0.00372	CcSEcCtD
Neomycin—Vomiting—Goserelin—prostate cancer	0.00349	0.00349	CcSEcCtD
Neomycin—Vomiting—Conjugated Estrogens—prostate cancer	0.00346	0.00346	CcSEcCtD
Neomycin—Erythema—Docetaxel—prostate cancer	0.00343	0.00343	CcSEcCtD
Neomycin—Anaphylactic shock—Etoposide—prostate cancer	0.00337	0.00337	CcSEcCtD
Neomycin—Infection—Etoposide—prostate cancer	0.00335	0.00335	CcSEcCtD
Neomycin—Erythema—Capecitabine—prostate cancer	0.00332	0.00332	CcSEcCtD
Neomycin—Nausea—Goserelin—prostate cancer	0.00326	0.00326	CcSEcCtD
Neomycin—Nausea—Conjugated Estrogens—prostate cancer	0.00323	0.00323	CcSEcCtD
Neomycin—Hypersensitivity—Estradiol—prostate cancer	0.00321	0.00321	CcSEcCtD
Neomycin—Pruritus—Estradiol—prostate cancer	0.00308	0.00308	CcSEcCtD
Neomycin—Hypersensitivity—Mitoxantrone—prostate cancer	0.00299	0.00299	CcSEcCtD
Neomycin—Diarrhoea—Estradiol—prostate cancer	0.00298	0.00298	CcSEcCtD
Neomycin—Erythema—Prednisone—prostate cancer	0.00296	0.00296	CcSEcCtD
Neomycin—Anaphylactic shock—Docetaxel—prostate cancer	0.0028	0.0028	CcSEcCtD
Neomycin—Infection—Docetaxel—prostate cancer	0.00278	0.00278	CcSEcCtD
Neomycin—Diarrhoea—Mitoxantrone—prostate cancer	0.00277	0.00277	CcSEcCtD
Neomycin—Vomiting—Estradiol—prostate cancer	0.00277	0.00277	CcSEcCtD
Neomycin—Infection—Capecitabine—prostate cancer	0.0027	0.0027	CcSEcCtD
Neomycin—Nausea—Estradiol—prostate cancer	0.00258	0.00258	CcSEcCtD
Neomycin—Vomiting—Mitoxantrone—prostate cancer	0.00258	0.00258	CcSEcCtD
Neomycin—Hypersensitivity—Etoposide—prostate cancer	0.00248	0.00248	CcSEcCtD
Neomycin—Anaphylactic shock—Prednisone—prostate cancer	0.00242	0.00242	CcSEcCtD
Neomycin—Nausea—Mitoxantrone—prostate cancer	0.00241	0.00241	CcSEcCtD
Neomycin—Infection—Prednisone—prostate cancer	0.0024	0.0024	CcSEcCtD
Neomycin—Pruritus—Etoposide—prostate cancer	0.00239	0.00239	CcSEcCtD
Neomycin—Erythema—Epirubicin—prostate cancer	0.00232	0.00232	CcSEcCtD
Neomycin—Diarrhoea—Etoposide—prostate cancer	0.00231	0.00231	CcSEcCtD
Neomycin—Vomiting—Etoposide—prostate cancer	0.00214	0.00214	CcSEcCtD
Neomycin—Erythema—Doxorubicin—prostate cancer	0.00214	0.00214	CcSEcCtD
Neomycin—Hypersensitivity—Docetaxel—prostate cancer	0.00206	0.00206	CcSEcCtD
Neomycin—Nausea—Etoposide—prostate cancer	0.002	0.002	CcSEcCtD
Neomycin—Hypersensitivity—Capecitabine—prostate cancer	0.002	0.002	CcSEcCtD
Neomycin—Pruritus—Docetaxel—prostate cancer	0.00198	0.00198	CcSEcCtD
Neomycin—Pruritus—Capecitabine—prostate cancer	0.00192	0.00192	CcSEcCtD
Neomycin—Diarrhoea—Docetaxel—prostate cancer	0.00192	0.00192	CcSEcCtD
Neomycin—Anaphylactic shock—Epirubicin—prostate cancer	0.00189	0.00189	CcSEcCtD
Neomycin—Infection—Epirubicin—prostate cancer	0.00188	0.00188	CcSEcCtD
Neomycin—Diarrhoea—Capecitabine—prostate cancer	0.00186	0.00186	CcSEcCtD
Neomycin—Vomiting—Docetaxel—prostate cancer	0.00178	0.00178	CcSEcCtD
Neomycin—Hypersensitivity—Prednisone—prostate cancer	0.00178	0.00178	CcSEcCtD
Neomycin—Anaphylactic shock—Doxorubicin—prostate cancer	0.00175	0.00175	CcSEcCtD
Neomycin—Infection—Doxorubicin—prostate cancer	0.00174	0.00174	CcSEcCtD
Neomycin—Vomiting—Capecitabine—prostate cancer	0.00173	0.00173	CcSEcCtD
Neomycin—Pruritus—Prednisone—prostate cancer	0.00171	0.00171	CcSEcCtD
Neomycin—Nausea—Docetaxel—prostate cancer	0.00166	0.00166	CcSEcCtD
Neomycin—Diarrhoea—Prednisone—prostate cancer	0.00165	0.00165	CcSEcCtD
Neomycin—Nausea—Capecitabine—prostate cancer	0.00161	0.00161	CcSEcCtD
Neomycin—Vomiting—Prednisone—prostate cancer	0.00154	0.00154	CcSEcCtD
Neomycin—Nausea—Prednisone—prostate cancer	0.00144	0.00144	CcSEcCtD
Neomycin—Hypersensitivity—Epirubicin—prostate cancer	0.00139	0.00139	CcSEcCtD
Neomycin—Pruritus—Epirubicin—prostate cancer	0.00134	0.00134	CcSEcCtD
Neomycin—Diarrhoea—Epirubicin—prostate cancer	0.00129	0.00129	CcSEcCtD
Neomycin—Hypersensitivity—Doxorubicin—prostate cancer	0.00129	0.00129	CcSEcCtD
Neomycin—Pruritus—Doxorubicin—prostate cancer	0.00124	0.00124	CcSEcCtD
Neomycin—Vomiting—Epirubicin—prostate cancer	0.0012	0.0012	CcSEcCtD
Neomycin—Diarrhoea—Doxorubicin—prostate cancer	0.0012	0.0012	CcSEcCtD
Neomycin—Nausea—Epirubicin—prostate cancer	0.00112	0.00112	CcSEcCtD
Neomycin—Vomiting—Doxorubicin—prostate cancer	0.00111	0.00111	CcSEcCtD
Neomycin—Nausea—Doxorubicin—prostate cancer	0.00104	0.00104	CcSEcCtD
